In CF testing, one of the most common types of molecular diagnostic screenings performed, laboratories use samples from patients with known mutations as a control.

Cite this: Regulating Molecular Diagnostic Assays - Medscape - May 01, 2011. Commenting is limited to medical professionals. To comment please Log-in.

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global animal and public health, announced today ...

Recent developments in the Molecular Diagnostics space have been aiding key MedTech players like BD (BDX) to boost their business.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...

Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work ...

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today the launch of their Vector Smart™ NAM-e multiplex ...

Eastern Europe Molecular Diagnostics Market to reach US$ 1.6 Bn by 2035, growing at 3.2% CAGR, driven by advanced testing adoption and healthcare expansion. WILMINGTON, DE, UNITED STATES, August 23, ...